2024-01-17 2025-01-31 false No description of principal activity Capium Accounts Production 1.1 15421978 2024-01-17 2025-01-31 15421978 bus:AbridgedAccounts 2024-01-17 2025-01-31 15421978 bus:Micro-entities 2024-01-17 2025-01-31 15421978 bus:AuditExempt-NoAccountantsReport 2024-01-17 2025-01-31 15421978 bus:SmallCompaniesRegimeForAccounts 2024-01-17 2025-01-31 15421978 bus:PrivateLimitedCompanyLtd 2024-01-17 2025-01-31 15421978 2024-01-17 2025-01-31 15421978 2025-01-31 15421978 bus:RegisteredOffice 2024-01-17 2025-01-31 15421978 core:WithinOneYear 2025-01-31 15421978 core:AfterOneYear 2025-01-31 15421978 1 2024-01-17 2025-01-31 15421978 bus:Director1 2024-01-17 2025-01-31 15421978 bus:Director1 2025-01-31 15421978 2023-01-17 15421978 bus:LeadAgentIfApplicable 2024-01-17 2025-01-31 15421978 2024-01-16 15421978 core:ComputerEquipment 2024-01-17 2025-01-31 15421978 core:ComputerEquipment 2025-01-31 15421978 core:ComputerEquipment 2024-01-16 15421978 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-01-31 15421978 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-01-16 15421978 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 15421978 core:CostValuation core:Non-currentFinancialInstruments 2024-01-16 15421978 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-01-31 15421978 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 15421978 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 15421978 core:Non-currentFinancialInstruments 2025-01-31 15421978 core:Non-currentFinancialInstruments 2024-01-16 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 15421978
England and Wales

 

 

 

PHARMAD LTD



Abridged Accounts
 


Period of accounts

Start date: 17 January 2024

End date: 31 January 2025
  2025
    £ £
Fixed assets   923 
Current assets 35,720   
Creditors: amount falling due within one year (7,213)  
Net current assets   28,507 
Total assets less current liabilities   29,430 
Accruals and deferred income   (132)
Net assets   29,298 
 

     
Capital and reserves   29,298 
 
NOTES TO THE ACCOUNTS

General Information
PHARMAD LTD is a private company, limited by shares, registered in England and Wales, registration number 15421978, registration address 85 GREAT PORTLAND STREET, FIRST FLOOR LONDON, W1W 7LT.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the period was 0.


For the period ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the director on 27 June 2025 and were signed by:


--------------------------------
Man-Ho Danny Leung
Director
1